Literature DB >> 19381754

Relationship between radiological knee osteoarthritis and biochemical markers of cartilage and bone degradation (urine CTX-II and NTX-I): the Matsudai Knee Osteoarthritis Survey.

Nobuchika Tanishi1, Hiroshi Yamagiwa, Tadashi Hayami, Hisashi Mera, Yoshio Koga, Go Omori, Naoto Endo.   

Abstract

Biochemical markers of cartilage and bone degradation are becoming increasingly important in the evaluation of knee osteoarthritis (OA). To clarify the correlation between radiological knee OA and urine CTX-II (C-terminal crosslinking telopeptide of collagen type II) or urine NTX-I (N-terminal crosslinking telopeptide of type I collagen), we conducted a cross-sectional study in the cohorts of the epidemiological knee survey at the Matsudai district in Niigata Prefecture, Japan. Urine specimens were collected from 296 subjects, and CTX-II and NTX-I were measured using ELISA. Standing knee AP X-rays were obtained and graded according to the Kellgren-Lawrence classification. The subjects were then divided by gender, age (40- to 59-year-old group and 60- to 79-year-old group), and the X-ray grade (Grade 0, 1, Grade 2, and Grade 3, 4). In non-OA (Grade 0, 1) subjects, the 60- to 79-year-old group had significantly higher CTX-II values than the younger group only in females. The subjects of both genders aged over 60 years of age with OA Grade 3, 4 had significantly higher CTX-II values than the Grade 0, 1 group or the Grade 2 group. For NTX-I, there were no significant differences between each OA grade although the Grade 3, 4 group females from 60 to 79 years of age had higher values than the Grade 2 group. In addition, in the 60- to 79-year-old subjects of both genders, a positive correlation was observed between the urine CTX-II and urine NTX-I. For the subjects ranging from 60 to 79 years of age in both genders, the urine CTX-II values indicate the progression of OA. In addition, the weak but positive correlation between urine CTX-II and urine NTX-I in the subjects ranging from 60 to 79 years of age in both genders suggests that bone resorption and cartilage degradation appear to develop in parallel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19381754     DOI: 10.1007/s00774-009-0077-3

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  19 in total

Review 1.  Inverse relationship osteoarthritis-osteoporosis: what is the evidence? What are the consequences?

Authors:  J Dequeker; S Boonen; J Aerssens; R Westhovens
Journal:  Br J Rheumatol       Date:  1996-09

2.  Effect of bisphosphonates on cartilage turnover assessed with a newly developed assay for collagen type II degradation products.

Authors:  H J Lehmann; U Mouritzen; S Christgau; P A C Cloos; C Christiansen
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

3.  Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: the Framingham Study.

Authors:  Y Zhang; M T Hannan; C E Chaisson; T E McAlindon; S R Evans; P Aliabadi; D Levy; D T Felson
Journal:  J Rheumatol       Date:  2000-04       Impact factor: 4.666

4.  An outcome measure for Japanese people with knee osteoarthritis.

Authors:  Masami Akai; Tokuhide Doi; Keiji Fujino; Tsutomu Iwaya; Hisashi Kurosawa; Teruo Nasu
Journal:  J Rheumatol       Date:  2005-08       Impact factor: 4.666

5.  The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model.

Authors:  Tadashi Hayami; Maureen Pickarski; Gregg A Wesolowski; Julia McLane; Ashleigh Bone; James Destefano; Gideon A Rodan; Le T Duong
Journal:  Arthritis Rheum       Date:  2004-04

6.  Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis.

Authors:  Robert Landewé; Piet Geusens; Maarten Boers; Désirée van der Heijde; Willem Lems; Johan te Koppele; Sjef van der Linden; Patrick Garnero
Journal:  Arthritis Rheum       Date:  2004-05

7.  Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits.

Authors:  T Sone; M Miyake; N Takeda; M Fukunaga
Journal:  Bone       Date:  1995-10       Impact factor: 4.398

8.  Increased levels of stromelysin-1 and tissue inhibitor of metalloproteinases-1 in sera from patients with rheumatoid arthritis.

Authors:  Y Yoshihara; K Obata; N Fujimoto; K Yamashita; T Hayakawa; M Shimmei
Journal:  Arthritis Rheum       Date:  1995-07

9.  Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index.

Authors:  U Mouritzen; S Christgau; H-J Lehmann; L B Tankó; C Christiansen
Journal:  Ann Rheum Dis       Date:  2003-04       Impact factor: 19.103

10.  Is pro-matrix metalloproteinase-3 a marker for posttraumatic cartilage degradation?

Authors:  K Bobacz; R Maier; C Fialka; H Ekhart; W Woloszczuk; G Geyer; L Erlacher; J Smolen; W B Graninger
Journal:  Osteoarthritis Cartilage       Date:  2003-09       Impact factor: 6.576

View more
  11 in total

Review 1.  The evolving role of biomarkers for osteoarthritis.

Authors:  Muneaki Ishijima; Haruka Kaneko; Kazuo Kaneko
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-08       Impact factor: 5.346

2.  Cartilage signal intensity on T1-weighted MRI: association with risk factors and measures of knee osteoarthritis.

Authors:  Oliver Patrick Stannus; Danchi Jiang; Flavia Cicuttini; Yuelong Cao; Changhai Ding
Journal:  Clin Rheumatol       Date:  2013-12-10       Impact factor: 2.980

3.  The relationship between urinary C-Telopeptide fragments of type II collagen, knee joint load, pain, and physical function in individuals with medial knee osteoarthritis.

Authors:  Luiz Fernando Approbato Selistre; Glaucia Helena Gonçalves; Fernando Augusto Vasilceac; Paula Regina Mendes da Silva Serrão; Theresa Helissa Nakagawa; Marina Petrella; Richard Keith Jones; Stela Márcia Mattiello
Journal:  Braz J Phys Ther       Date:  2020-02-26       Impact factor: 3.377

4.  Urinary CTX-II concentrations are elevated and associated with knee pain and function in subjects with ACL reconstruction.

Authors:  T L Chmielewski; T N Trumble; A-M Joseph; J Shuster; P A Indelicato; M W Moser; F M Cicuttini; C Leeuwenburgh
Journal:  Osteoarthritis Cartilage       Date:  2012-08-02       Impact factor: 6.576

Review 5.  C-Terminal Cross-Linked Telopeptides of Type II Collagen as Biomarker for Radiological Knee Osteoarthritis: A Meta-Analysis.

Authors:  HongBin Cheng; Baoxi Hao; Jingtao Sun; Mingxi Yin
Journal:  Cartilage       Date:  2018-09-15       Impact factor: 4.634

6.  Combined detection of serum CTX-II and COMP concentrations in osteoarthritis model rabbits: an effective technique for early diagnosis and estimation of disease severity.

Authors:  Bin Bai; Yanqin Li
Journal:  J Orthop Surg Res       Date:  2016-11-22       Impact factor: 2.359

7.  Expression of synovial fluid biomarkers in patients with knee osteoarthritis and meniscus injury.

Authors:  Jian Ding; Xin Niu; Yan Su; Xiaolin Li
Journal:  Exp Ther Med       Date:  2017-06-21       Impact factor: 2.447

8.  Meta-analysis of urinary C-terminal telopeptide of type II collagen as a biomarker in osteoarthritis diagnosis.

Authors:  Mingjian Huang; Jingyu Zhao; Yan Huang; Liming Dai; Xiaoling Zhang
Journal:  J Orthop Translat       Date:  2017-08-15       Impact factor: 5.191

9.  High uric acid (UA) downregulates bone alkaline phosphatase (BALP) expression through inhibition of its promoter activity.

Authors:  Zhi-Qi Wu; Xiao-Ting Chen; Yan-Yan Xu; Ming-Jie Tian; Hai-Yan Chen; Guo-Ping Zhou; Hua-Guo Xu
Journal:  Oncotarget       Date:  2017-09-20

10.  Low Bone Mineral Density and High Bone Turnover in Patients With Non-Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study.

Authors:  Konstantinos Anargyrou; Despina Fotiou; Theodoros P Vassilakopoulos; Dimitrios Christoulas; Polyzois Makras; Maria Dimou; Ioannis Ntanasis-Stathopoulos; Stavroula Masouridou; Maria K Angelopoulou; Athanasios Papatheodorou; Konstantinos Tsionos; Panayiotis Panayiotidis; Meletios A Dimopoulos; Evangelos Terpos
Journal:  Hemasphere       Date:  2019-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.